Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT) (SELECT)
Deep Vein Thrombosis
About this trial
This is an interventional diagnostic trial for Deep Vein Thrombosis focused on measuring deep vein thrombosis, pulmonary embolism, D-dimer testing
Eligibility Criteria
Inclusion Criteria: Age 18 and older Presenting with symptoms compatible with clinically suspected deep vein thrombosis Exclusion Criteria: Treatment with full dose anticoagulation for 24 hours or more. Other test for deep vein thrombosis already performed. Ongoing need for therapeutic anticoagulant therapy. Life expectancy less than 3 months. Absence of acute symptoms within 7 days of presentation. Presenting with symptoms of pulmonary embolism. Previous confirmed episode of deep vein thrombosis or pulmonary embolism. Current pregnancy. Geographic inaccessibility which precludes follow-up.
Sites / Locations
- Hamilton Health Sciences, McMaster
- St. Joseph's Health Care Centre
- Hamilton Health Sciences, Henderson
- Hamilton Health Sciences, General
- SMBD Jewish General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2
Selective D-Dimer use
Uniform D-Dimer use